Crinetics Pharmaceuticals, Inc. (CRNX) Total liabilities 2017–2025
Crinetics Pharmaceuticals, Inc. (CRNX) total liabilities at each fiscal year-end, per SEC filings.
$134.2MFY2025 · since FY2017: $920,000 → $134.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $134.2M | +22.2% |
| FY2024 | $109.8M | +14.1% |
| FY2023 | $96.2M | +168.5% |
| FY2022 | $35.8M | +88.0% |
| FY2021 | $19.1M | +31.3% |
| FY2020 | $14.5M | +9.7% |
| FY2019 | $13.2M | +18.3% |
| FY2018 | $11.2M | +1116.3% |
| FY2017 | $920,000 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice